No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Plasma Epstein-Barr virus DNA may have prognostic value for patients with nasopharyngeal carcinoma

byTeddy Guo

June 10, 2021

in StudyGraphics

Reading Time: 1 min read

Click to read the study in Clinical Cancer Research.

RELATED REPORTS

#VisualAbstract: Adjuvant PD-1 Blockade With Camrelizumab Improves Survival in Nasopharyngeal Carcinoma

#VisualAbstract: Atezolizumab Does Not Improve Outcomes in High-Risk Locally Advanced Head and Neck Squamous Cell Carcinoma

High incidence of post-transplant lymphoproliferative disorder in Epstein-Barr virus-seronegative kidney recipients

#VisualAbstract: High-dose methylprednisolone vs. dexamethasone for COVID-19 pneumonia

RelatedReports

StudyGraphics

#VisualAbstract: Adjuvant PD-1 Blockade With Camrelizumab Improves Survival in Nasopharyngeal Carcinoma

March 26, 2025

StudyGraphics

#VisualAbstract: Atezolizumab Does Not Improve Outcomes in High-Risk Locally Advanced Head and Neck Squamous Cell Carcinoma

March 24, 2025

Adaptive interim PET-CT guides treatment for advanced Hodgkin’s lymphoma

Oncology

High incidence of post-transplant lymphoproliferative disorder in Epstein-Barr virus-seronegative kidney recipients

January 27, 2025

The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Jamie Foxx Back in Action, Paracetamol for Pain, FDA Against Addictive Vape Flavours, and Coffee and Tea, Beyond Caffeine:

January 7, 2025

#VisualAbstract Cutaneous reactions in children treated with MEK and/or BRAF inhibitors are common and often lead to interruptions or alterations in chemotherapy

Ziltivekimab antagonism of IL-6 reduces inflammation and thrombosis in patients with atherosclerotic risk factors

Wellness Check: Mental Health

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result